Post-IPO Debt Biotechnology Companies

Zoetis is an animal health company that advances care for animals and supports their health and wellbeing.

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs.

Cell Source focuses on developing cell therapy treatments based on the management of immune tolerance.

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

TGOD grows high quality, organic cannabis with sustainable, all-natural principles. TGOD has a funded capacity of 116,000 kg.

Cereno Scientific develops therapies for cardiovascular diseases using epigenetic modulation and advances drug candidates like CS1.

Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Ocean Biomedical is a biotechnology company that partners with researchers to accelerate new discoveries in medical industry.

Delorean Corp. provides bioenergy and commercial production of renewable gas in the form of biomethane.